2004 Lowbury Lecture: the Western Australian experience with vancomycin-resistant enterococci - from disaster to ongoing control

Journal of Hospital Infection

Volumn 63, Issue 1, 2006, Pages 14-26

  Pearman, J W ^a  

^a ROYAL PERTH HOSPITAL   (Australia)

Author keywords

Enterococcus faecium; Infection control strategies; Vancomycin resistant enterococci

Indexed keywords

AMOXICILLIN; BACITRACIN; BACTERIAL PROTEIN; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; CLAVULANIC ACID; CLOSTRIDIUM TOXIN; GENTAMICIN; METRONIDAZOLE; PENICILLIN DERIVATIVE; PENICILLIN G; TEICOPLANIN; TICARCILLIN; UNCLASSIFIED DRUG; VANA PROTEIN; VANB PROTEIN; VANCOMYCIN; VANB PROTEIN, ENTEROCOCCUS;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; AUSTRALIA; BACTERIAL COLONIZATION; BACTERIAL STRAIN; BACTERIUM CARRIER; BACTERIUM CONTAMINATION; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BONE MARROW TRANSPLANTATION; BURN UNIT; CLOSTRIDIUM DIFFICILE; DIALYSIS; DISABLED PERSON; DISINFECTION; ENRICHMENT CULTURE; ENTEROCOCCAL INFECTION; ENVIRONMENTAL FACTOR; EPIDEMIC; EPIDEMIOLOGICAL DATA; ERADICATION THERAPY; FECES CULTURE; FOLLOW UP; GENOTYPE; GERIATRIC PATIENT; HEMATOLOGY; HETEROZYGOTE DETECTION; HOSPITAL ADMINISTRATOR; HOSPITAL ADMISSION; HOSPITAL COST; HOSPITAL DEPARTMENT; HOSPITAL DISCHARGE; HOSPITAL FINANCE; HOSPITAL INFECTION; HOSPITAL PATIENT; HOSPITAL READMISSION; HOSPITAL SERVICE; HUMAN; INFECTION CONTROL; INFECTION RISK; INTENSIVE CARE UNIT; LABORATORY TEST; MEDICAL RECORD; MICROBIOLOGICAL EXAMINATION; NEPHROLOGY; NONHUMAN; OUTPATIENT DEPARTMENT; PATIENT CARE; PATIENT TRANSPORT; PLASMID; POLYMERASE CHAIN REACTION; PULSED FIELD GEL ELECTROPHORESIS; RECTUM; RESIDENTIAL CARE; SCREENING TEST; VANCOMYCIN RESISTANT ENTEROCOCCUS; BACTERIAL INFECTION; CROSS INFECTION; DISEASE TRANSMISSION; DRUG EFFECT; ECONOMICS; ENTEROCOCCUS FAECIUM; HETEROZYGOTE; ISOLATION AND PURIFICATION; METHODOLOGY; MICROBIOLOGY; PATHOGENICITY;

BACTERIAL PROTEINS; CARRIER STATE; CROSS INFECTION; DISEASE OUTBREAKS; ELECTROPHORESIS, GEL, PULSED-FIELD; ENTEROCOCCUS FAECIUM; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; INFECTION CONTROL; VANCOMYCIN RESISTANCE; WESTERN AUSTRALIA;

EID: 33745032306     PISSN: 01956701     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhin.2005.10.017     Document Type: Article

References (29)

1. Lowbury E. 'Apocryphal letter Joseph to Arthur Lister'. In: Lowbury: collected poems 1934-1992. Frome: Hippopotamus Press, 1993.
2. Scheckler W.E., Brimhall D., Buck A.S., et al. Requirements for infrastructure and essential activities of infection control and hospital epidemiology in hospitals: a consensus panel report. Infect Control Hosp Epidemiol 19 (1998) 114-124
3. Bell J.M., Paton J.C., and Turnidge J. Emergence of vancomycin-resistant enterococci in Australia: phenotypic and genotypic characteristics of isolates. J Clin Microbiol 36 (1998) 2187-2190
4. Ballard S.A., Grabsch E.A., Xie S., et al. Correlation of the detection of vanB genes in faeces to the presence of vancomycin-resistant enterococci (VRE): interference by vanB-containing anaerobes. Aust Soc Antimicrob News 15 (2003) 4
5. Pearman J.W., Peterson A.M., Lee R.C., et al. The epidemiology of a large single-strain outbreak of Enterococcus faecium vanB in an Australian teaching hospital. Aust Infect Control 8 (2003) 77-87
6. Boyce J.M., Opal S.M., Chow J.W., et al. Outbreak of multidrug-resistant Enterococcus faecium with transferable vanB class vancomycin resistance. J Clin Microbiol 32 (1994) 1148-1153
7. Christiansen K.J., Tibbett P.A., Beresford W., et al. Eradication of a large outbreak of a single-strain of vanB vancomycin-resistant Enterococcus faecium at a major Australian teaching hospital. Infect Control Hosp Epidemiol 25 (2004) 384-390
8. Pearman J.W., Perry P.L., Kosaras F.P., et al. Screening and electronic labelling of ward contacts of vancomycin-resistant Enterococcus faecium vanB carriers during a single-strain hospital outbreak and after discharge from hospital. Commun Dis Intell 27 Suppl (2003) S97-S102
9. Palladino S., Kay I.D., Costa A.M., et al. Real-time PCR for the rapid detection of vanA and vanB genes. Diagn Microbiol Infect Dis 45 (2003) 81-84
10. Palladino S., Kay I.D., Flexman J.P., et al. Rapid detection of vanA and vanB genes directly from clinical specimens and enrichment broths by real-time multiplex PCR assay. J Clin Microbiol 41 (2003) 2483-2486
11. Dutka-Malen S., Evers S., and Courvalin P. Detection of glycopeptide resistance genotypes and identification to the species level of clinically relevant enterococci by PCR. J Clin Microbiol 33 (1995) 24-27
12. Brennen C., Wagener M.M., and Muder R.R. Vancomycin-resistant Enterococcus faecium in a long-term care facility. J Am Geriatr Soc 46 (1998) 157-160
13. Carmeli Y., Eliopoulos G., Mozaffari E., and Samore M. Health and economic outcomes of vancomycin-resistant enterococci. Arch Intern Med 162 (2002) 2223-2228
14. Muto C.A., Giannetta E.T., Durbin L.J., et al. Cost-effectiveness of perirectal surveillance cultures for controlling vancomycin-resistant Enterococcus. Infect Control Hosp Epidemiol 23 (2002) 429-435
15. Vicca A.F. Nursing staff workload as a determinant of methicillin-resistant Staphylococcus aureus spread in an adult intensive therapy unit. J Hosp Infect 43 (1999) 109-113
16. Farrington M., Trundle C., Redpath C., and Anderson L. Effects on nursing workload of different methicillin-resistant Staphylococcus aureus (MRSA) control strategies. J Hosp Infect 46 (2000) 118-122
17. Cooper PB, Pearman JW, Tenni PC, Burke V. The influence of prior antibiotic consumption on the acquisition of vancomycin-resistant Enterococcus faecium vanB by patients during a single-strain hospital outbreak. Unpublished observations.
18. Byers K.E., Anglim A.M., Anneski C.J., et al. A hospital epidemic of vancomycin-resistant Enterococcus: risk factors and control. Infect Control Hosp Epidemiol 22 (2001) 140-147
19. Ostrowsky B.E., Trick W.E., Sohn A.H., et al. Control of vancomycin-resistant enterococcus in health care facilities in a region. N Engl J Med 344 (2001) 1427-1433
20. Hatchem R., Graviss L., Hanna H., et al. Impact of surveillance for vancomycin-resistant enterococci on controlling a bloodstream outbreak among patients with hematologic malignancy. Infect Control Hosp Epidemiol 25 (2004) 391-394
21. Boyce J.M., Havill N.L., Kohan C., et al. Do infection control measures work for methicillin-resistant Staphylococcus aureus?. Infect Control Hosp Epidemiol 25 (2004) 395-401
22. Jarvis W.R. Editorial. Controlling antimicrobial-resistant pathogens. Infect Control Hosp Epidemiol 25 (2004) 369-372
23. Fitzpatrick F, Humphreys H, Solanki D, Smyth EG. Assertive antibiotic stewardship cuts hospital antibiotic costs. In: Fifth International Conference of the Hospital Infection Society, Edinburgh, UK; 15-18 September 2002. p. 51.
24. Westh H., Zinn C.S., Rosdahl V.T., and SARISA study group. An international multicenter study of antimicrobial consumption and resistance in Staphylococcus aureus isolates from 15 hospitals in 14 countries. Microb Drug Resist 10 (2004) 169-176
25. Montecalvo M.A., de Lencastre H., Carraher M., et al. Natural history of colonization with vancomycin-resistant Enterococcus faecium. Infect Control Hosp Epidemiol 16 (1995) 680-685
26. Dahms R.A., Johnson E.M., Statz C.L., et al. Third-generation cephalosporins and vancomycin as risk factors for postoperative vancomycin-resistant Enterococcus infection. Arch Surg 133 (1998) 1343-1346
27. Donskey C.J., Hanrahan J.A., Hutton R.A., and Rice L.B. Effect of parenteral antibiotic administration on persistance of vancomycin-resistant Enterococcus faecium in the mouse gastrointestinal tract. J Infect Dis 180 (1999) 384-390
28. Donskey C.J., Chowdhry T.K., Hecker M.T., et al. Effect of antibiotic therapy on the density of vancomycin-resistant enterococci in the stool of colonized patients. N Engl J Med 343 (2000) 1925-1932
29. Lautenbach E., La Rosa L.A., Marr A.M., et al. Changes in the prevalence of vancomycin-resistant enterococci in response to antimicrobial formulary interventions: impact of progressive restrictions on use of vancomycin and third-generation cephalosporins. Clin Infect Dis 36 (2003) 440-446